PTO/SB/30EFS (02-18)
`Doc code: RCEX
`Approved for use through 11/30/2020. OMB 0651-0031
`Doc description: Request for Continued Examination (RCE)
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`REQUEST FOR CONTINUED EXAM|NAT|ON(RCE)TRANSM|TTAL
`(Submitted Only via EFS-Web)
`
`Application
`Number
`First Named
`Inventor
`
`15808632
`
`Filing
`Date
`
`_
`_
`2017 11 09
`
`Gregory D. Jay
`
`Docket Number
`(if applicable)
`Examiner
`Name
`
`_
`LUB 030
`
`L. N. Komatsu
`
`Art
`Unit
`
`1658
`
`This is a Request for Continued Examination (RCE) under 37 CFR 1.114 of the above-identified application.
`Request for Continued Examination (RCE) practice under 37 CFR1.114 does not apply to any utility or plant application filed prior to June 8,
`1995, orto any design application. The Instruction Sheet for this form is located at WWW.USPTO.GOV
`
`SUBMISSION REQUIRED UNDER 37 CFR1.114
`
`Note: lfthe RCE is proper, any previously filed unentered amendments and amendments enclosed with the RCE will be entered in the order
`in which they were filed unless applicant instructs othenNise. lfapplicant does not wish to have any previously filed unentered amendment(s)
`entered, applicant must request non-entry ofsuch amendment(s).
`
`1:1 Previously submitted. lfa final Office action is outstanding, any amendments filed after the final Office action may be considered as a
`submission even ifthis box is not checked.
`
`|:| Consider the arguments in the Appeal Brief or Reply Brief previously filed on
`
`|:| Other
`
`|Z| Enclosed
`
`|X| Amendment/Reply
`
`|X|
`
`Information Disclosure Statement (IDS)
`
`|:| Affidavit(s)/ Declaration(s)
`
`|:| Other
`
`|:| Applicant Signature
`
`1:1 Suspension of action on the above-identified application is requested under 37 CFR 1.103(c) for a period of months
`(Period ofsuspension shall not exceed 3 months; Fee under 37 CFR1.17(i) required)
`
`MISCELLANEOUS
`
`D Other
`
`The RCE fee under 37 CFR1.17(e) is required by 37 CFR1.114 when the RCE is filed.
`|Z| The Director is hereby authorized to charge any underpayment of fees, or credit any overpayments, to
`Deposit Account No
`07-1700
`
`SIGNATURE OF APPLICANT, ATTORNEY, OR AGENT REQUIRED
`
`FEES
`
`|Z Patent Practitioner Signature
`
`EFS - Web 2.1.16
`
`

`

`PTO/SB/30EFS (02-18)
`Doc code: RCEX
`Approved for use through 11/30/2020. OMB 0651-0031
`Doc description: Request for Continued Examination (RCE)
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`
`
`Name
`
`Crystal A. Komm
`
`Signature of Registered U.S. Patent Practitioner
`
`Registration Number
`
`67343
`
`This collection of information is required by 37 CFR 1.114. The information is required to obtain or retain a benefit by the public which is to
`file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR1.11 and 1.14. This collection is
`estimated to take 12 minutes to complete, including gathering, preparing, and submitting the completed application form to the USPTO. Time
`will vary depending upon the individual case. Any comments on the amount oftime you require to complete this form and/or suggestions for
`reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and Trademark Office, U.S. Department of Commerce,
`PO. Box 1450, Alexandria, VA 22313-1450.
`If you need assistance in completing the form, call 1-800-PTO-9199 and select option 2.
`
`EFS - Web 2.1.16
`
`

`

`Privacy Act Statement
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1.
`
`The information on this form will be treated confidentially to the extent allowed underthe Freedom of Information
`Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the
`Department ofJustice to determine whether the Freedom of Information Act requires disclosure ofthese records.
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission ofthe
`attached form related to a patent application or patent. Accordingly, pursuant to the requirements ofthe Act, please be
`advised that:
`(1) the general authority forthe collection ofthis information is 35 U.S.C. 2(b)(2); (2) furnishing ofthe information
`solicited is voluntary; and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark Office
`is to process and/or examine your submission related to a patent application or patent.
`If you do not furnish the requested
`information, the U.S. Patent and Trademark Office may not be able to process and/or examine your submission, which may
`result in termination of proceedings or abandonment ofthe application or expiration of the patent.
`
`enforcement agency, ifthe USPTO becomes aware of a violation or potential violation of law or regulation.
`
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a
`court, magistrate, or administrative tribunal, including disclosures to opposing counsel in the course of settlement
`negotiations.
`
`A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a
`request involving an individual, to whom the record pertains, when the individual has requested assistance from the
`Member with respect to the subject matter ofthe record.
`
`A record in this system of records may be disclosed, as a routine use, to a contractor ofthe Agency having need
`forthe information in orderto perform a contract. Recipients of information shall be required to comply with the
`requirements ofthe Privacy Act of 1974, as amended, pursuant to 5 U.S.C. 552a(m).
`
`A record related to an International Application filed underthe Patent Cooperation Treaty in this system of records
`may be disclosed, as a routine use, to the International Bureau ofthe World Intellectual Property Organization,
`pursuant to the Patent Cooperation Treaty.
`
`A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes of
`National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services,
`or his/herdesignee, during an inspection of records conducted by GSA as part ofthat agency's responsibility to
`recommend improvements in records management practices and programs, under authority of 44 U.S.C. 2904 and
`2906. Such disclosure shall be made in accordance with the GSA regulations governing inspection of records for this
`purpose, and any other relevant (i.e., GSA or Commerce) directive. Such disclosure shall not be used to make
`determinations about individuals.
`
`A record from this system of records may be disclosed, as a routine use, to the public after either publication of
`the application pursuant to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record may
`be disclosed, subject to the limitations of 37 CFR 1.14, as a routine use, to the public ifthe record was filed in an
`application which became abandoned or in which the proceedings were terminated and which application is
`referenced by either a published application, an application open to public inspections or an issued patent.
`
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law
`
`EFS - Web 2.1.16
`
`